Cargando…
SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
The novel coronavirus pneumonia, which was named later as coronavirus disease 2019 (COVID-19), is caused by the severe acute respiratory syndrome coronavirus 2, namely SARS-CoV-2. It is a positive-strand RNA virus that is the seventh coronavirus known to infect humans. The COVID-19 outbreak presents...
Autores principales: | TAŞTAN, Cihan, YURTSEVER, Bulut, SIR KARAKUŞ, Gözde, DİLEK KANÇAĞI, Derya, DEMİR, Sevda, ABANUZ, Selen, SEYİS, Utku, YILDIRIM, Mülazim, KUZAY, Recai, ELİBOL, Ömer, ARBAK, Serap, AÇIKEL ELMAS, Merve, BİRDOĞAN, Selçuk, SEZERMAN, Osman Uğur, KOCAGÖZ, Ayşe Sesin, YALÇIN, Koray, OVALI, Ercüment |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314506/ https://www.ncbi.nlm.nih.gov/pubmed/32595356 http://dx.doi.org/10.3906/biy-2004-113 |
Ejemplares similares
-
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
por: Sir Karakus, Gozde, et al.
Publicado: (2021) -
In Vitro FVIII-Encoding Transgenic Mesenchymal Stem Cells Maintain Successful Coagulation in FVIII-Deficient Plasma Mimicking Hemophilia A
por: Hemşinlioğlu, Cansu, et al.
Publicado: (2023) -
Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice
por: Turan, Raife Dilek, et al.
Publicado: (2021) -
Preclinical Assessment of Efficacy and Safety Analysis of CAR-T Cells (ISIKOK-19) Targeting CD19-Expressing B-Cells for the First Turkish Academic Clinical Trial with Relapsed/Refractory ALL and NHL Patients
por: Taştan, Cihan, et al.
Publicado: (2020) -
Mutational landscape of SARS-CoV-2 genome in Turkey and impact of mutations on spike protein structure
por: Hatirnaz Ng, Ozden, et al.
Publicado: (2021)